Delivery Order SPE2DR25D1201-SPE2DR26FAJYS
- Not listed
- The Defense Logistics Agency awarded a $74,312.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with an ultimate completion date of November 25, 2025. This contract was competitively awarded with no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,607.60 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a completion date of November 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract action under AmerisourceBergen's larger federal contract portfolio. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $31,613.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on October 29, 2025, with a completion date of October 30, 2025. This competitive award, which carries no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the contractor's location in...
- The Defense Logistics Agency awarded a $32,178.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on December 1, 2025, with completion scheduled for December 2, 2025. This non-set-aside award was issued from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,668.28 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) with a completion date of November 17, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations for federal...
- The Defense Logistics Agency awarded a $11,097.32 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count supply). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 23, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $40,498.66 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract, which carries no set-aside designation, was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $11,102.78 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) with an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $34,278.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a non-set-aside competitive award with an ultimate completion date of September 15, 2025, and performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11,522.91 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on September 12, 2025, with completion scheduled for September 15, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAJYSDelivery Order
The Defense Logistics Agency awarded a $116,824.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) with an ultimate completion date of December 2, 2025. This competitively awarded contract, without set-aside designation, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies and medications to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Trelegy Ellipta is a combination respiratory maintenance medication used in chronic obstructive pulmonary disease treatment, reflecting the broad therapeutic range of pharmaceuticals the company supplies through its federal contracts. The vendor's extensive portfolio of DLA awards demonstrates its established capability to meet federal procurement requirements through open competition, with delivery orders typically utilizing firm fixed pricing across varying transaction values to support military and veteran healthcare initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $116.8k | 11/30/25 |